48 research outputs found

    Imperfection sensitivity of pyramidal core sandwich structures

    Get PDF
    AbstractLightweight metallic truss structures are currently being investigated for use within sandwich panel construction. These new material systems have demonstrated superior mechanical performance and are able to perform additional functions, such as thermal management and energy amelioration. The subject of this paper is an examination of the mechanical response of these structures. In particular, the retention of their stiffness and load capacity in the presence of imperfections is a central consideration, especially if they are to be used for a wide range of structural applications. To address this issue, sandwich panels with pyramidal truss cores have been tested in compression and shear, following the introduction of imperfections. These imperfections take the form of unbound nodes between the core and face sheets—a potential flaw that can occur during the fabrication process of these sandwich panels. Initial testing of small scale samples in compression provided insight into the influence of the number of unbound nodes but more importantly highlighted the impact of the spatial configuration of these imperfect nodes. Large scale samples, where bulk properties are observed and edge effects minimized, have been tested. The stiffness response has been compared with finite element simulations for a variety of unbound node configurations. Results for fully bound cores have also been compared to existing analytical predictions. Experimentally determined collapse strengths are also reported. Due to the influence of the spatial configuration of unbound nodes, upper and lower limits on stiffness and strength have been determined for compression and shear. Results show that pyramidal core sandwich structures are robust under compressive loading. However, the introduction of these imperfections causes rapid degradation of core shear properties

    IMECE 2003-43377 HIGH AUTHORITY MORPHING STRUCTURES

    Get PDF
    ABSTRACT Recent advances in actuation technology and multifunctional materials have presented a unique opportunity to develop structures that have the ability to morph to a variety of shapes while under significant load constraints. One of the many applications of these "high-authority" systems is for morphing air wings for control and drag reduction. The exciting solution to this is the creation of a statically determinate structure that incorporates linear actuators to produce morphing capabilities. Statically determinate structures satisfy Maxwell's necessary condition that the number of member forces equal the number of joint equilibrium equations. By imposing this condition on the structure it is possible to actively change the shape of the overall structure without resulting in failure. In a morphing foil, the only induced strain within passive members will be due to the hydrodynamic forces present. Deformation of the truss members is stretch-dominated-they do not experience bending-and thus improve the load carrying capacity of the structure. Of primary interest are Shape Memory Alloy (SMAs) actuators. SMAs are useful for shape morphing concepts where large forces are needed. A prototypical foil has been built around a statically determinate structure that incorporates linear actuators to produce morphing capabilities. These "smart" foils have been tested in a wind tunnel to examine their drag reduction capabilities

    Kinematics of swimming of the manta ray: three-dimensional analysis of open water maneuverability

    Get PDF
    For aquatic animals, turning maneuvers represent a locomotor activity that may not be confined to a single coordinate plane, making analysis difficult particularly in the field. To measure turning performance in a three-dimensional space for the manta ray (Mobula birostris), a large open-water swimmer, scaled stereo video recordings were collected. Movements of the cephalic lobes, eye and tail base were tracked to obtain three-dimensional coordinates. A mathematical analysis was performed on the coordinate data to calculate the turning rate and curvature (1/turning radius) as a function of time by numerically estimating the derivative of manta trajectories through three-dimensional space. Principal component analysis (PCA) was used to project the three-dimensional trajectory onto the two-dimensional turn. Smoothing splines were applied to these turns. These are flexible models that minimize a cost function with a parameter controlling the balance between data fidelity and regularity of the derivative. Data for 30 sequences of rays performing slow, steady turns showed the highest 20% of values for the turning rate and smallest 20% of turn radii were 42.65+16.66 deg s-1 and 2.05+1.26 m, respectively. Such turning maneuvers fall within the range of performance exhibited by swimmers with rigid bodies

    Hydrodynamic Performance of Aquatic Flapping: Efficiency of Underwater Flight in the Manta

    Get PDF
    The manta is the largest marine organism to swim by dorsoventral oscillation (flapping) of the pectoral fins. The manta has been considered to swim with a high efficiency stroke, but this assertion has not been previously examined. The oscillatory swimming strokes of the manta were examined by detailing the kinematics of the pectoral fin movements swimming over a range of speeds and by analyzing simulations based on computational fluid dynamic potential flow and viscous models. These analyses showed that the fin movements are asymmetrical up- and downstrokes with both spanwise and chordwise waves interposed into the flapping motions. These motions produce complex three-dimensional flow patterns. The net thrust for propulsion was produced from the distal half of the fins. The vortex flow pattern and high propulsive efficiency of 89% were associated with Strouhal numbers within the optimal range (0.2–0.4) for rays swimming at routine and high speeds. Analysis of the swimming pattern of the manta provided a baseline for creation of a bio-inspired underwater vehicle, MantaBot

    Effect of angiotensin-converting enzyme inhibitor and angiotensin receptor blocker initiation on organ support-free days in patients hospitalized with COVID-19

    Get PDF
    IMPORTANCE Overactivation of the renin-angiotensin system (RAS) may contribute to poor clinical outcomes in patients with COVID-19. Objective To determine whether angiotensin-converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) initiation improves outcomes in patients hospitalized for COVID-19. DESIGN, SETTING, AND PARTICIPANTS In an ongoing, adaptive platform randomized clinical trial, 721 critically ill and 58 non–critically ill hospitalized adults were randomized to receive an RAS inhibitor or control between March 16, 2021, and February 25, 2022, at 69 sites in 7 countries (final follow-up on June 1, 2022). INTERVENTIONS Patients were randomized to receive open-label initiation of an ACE inhibitor (n = 257), ARB (n = 248), ARB in combination with DMX-200 (a chemokine receptor-2 inhibitor; n = 10), or no RAS inhibitor (control; n = 264) for up to 10 days. MAIN OUTCOMES AND MEASURES The primary outcome was organ support–free days, a composite of hospital survival and days alive without cardiovascular or respiratory organ support through 21 days. The primary analysis was a bayesian cumulative logistic model. Odds ratios (ORs) greater than 1 represent improved outcomes. RESULTS On February 25, 2022, enrollment was discontinued due to safety concerns. Among 679 critically ill patients with available primary outcome data, the median age was 56 years and 239 participants (35.2%) were women. Median (IQR) organ support–free days among critically ill patients was 10 (–1 to 16) in the ACE inhibitor group (n = 231), 8 (–1 to 17) in the ARB group (n = 217), and 12 (0 to 17) in the control group (n = 231) (median adjusted odds ratios of 0.77 [95% bayesian credible interval, 0.58-1.06] for improvement for ACE inhibitor and 0.76 [95% credible interval, 0.56-1.05] for ARB compared with control). The posterior probabilities that ACE inhibitors and ARBs worsened organ support–free days compared with control were 94.9% and 95.4%, respectively. Hospital survival occurred in 166 of 231 critically ill participants (71.9%) in the ACE inhibitor group, 152 of 217 (70.0%) in the ARB group, and 182 of 231 (78.8%) in the control group (posterior probabilities that ACE inhibitor and ARB worsened hospital survival compared with control were 95.3% and 98.1%, respectively). CONCLUSIONS AND RELEVANCE In this trial, among critically ill adults with COVID-19, initiation of an ACE inhibitor or ARB did not improve, and likely worsened, clinical outcomes. TRIAL REGISTRATION ClinicalTrials.gov Identifier: NCT0273570
    corecore